Table 1.
Baseline characteristics of patients included in the study; n = 131
| Baseline characteristic | Value |
|---|---|
| Age (years), median (i.q.r.) | 69.1 (63.7–73.1) |
| Sex, male | 100 (76.3) |
| Histology | |
| Adenocarcinoma | 93 (71.0) |
| Squamous cell carcinoma | 36 (27.5) |
| Other | 2 (1.5) |
| Tumour location | |
| Proximal oesophagus | 2 (1.5) |
| Middle oesophagus | 18 (13.7) |
| Distal–GOJ | 111 (84.7) |
| Tumour differentiation | |
| Good–moderate | 87 (66.4) |
| Poor | 39 (29.8) |
| Unknown | 5 (3.8) |
| cT stage | |
| cT2 | 27 (20.6) |
| cT3 | 91 (69.5) |
| cT4a | 2 (1.5) |
| cTx | 11 (8.4) |
| cN stage | |
| cN0 | 60 (45.8) |
| cN1 | 46 (35.1) |
| cN2 | 15 (11.5) |
| cN3 | 3 (2.3) |
| cNx | 13 (5.3) |
| Tumour circumference (endoscopy) | |
| 0–25% | 15 (11.5) |
| 26–50% | 33 (25.2) |
| 51–75% | 22 (16.8) |
| >75% | 33 (25.2) |
| Unknown | 28 (21.3) |
| Tumour length (cm on endoscopy), median (i.q.r.) | 5.0 (3.0–6.0) |
| Tumour length (cm on CT), median (i.q.r.) | 4.7 (4.0–6.0) |
Values are n (%) unless otherwise indicated. Numbers may not add up to 100 per cent due to rounding. i.q.r., interquartile range; GOJ, gastro-oesophageal junction; cT stage, clinical tumour stage; cN stage, clinical nodal stage.